Who is eligible to apply for Alembic Pharma rights issue?

Existing shareholders of Alembic Pharma as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.

How can existing shareholders apply for Alembic Pharma rights issue?

Shareholders can apply for Alembic Pharma rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.

Is the rights issue of Alembic Pharma mandatory for existing shareholders?

No! Participation in Alembic Pharma rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.

Has Alembic Pharma announced any rights issues in the past?

No, Alembic Pharma hasn’t had any right issues as of {{current_date}} in last 2023-2025

What was the last rights issue price and ratio for Alembic Pharma?

No, Alembic Pharma hasn’t had any right issues as of {{current_date}} in last 2023-2025

Alembic Pharmaceuticals Ltd. Rights Issue

Alembic Pharmaceuticals Ltd. has not split the face value of the share since 29 Aug, 2023

₹796.90₹796.90+2.05 (0.26%)

Last updated on 30 Oct, 2026 | 09:00 IST

Dividends
Splits
Bonus
Rights

Alembic Pharmaceuticals . Rights Issue Details

Rights Ratio
No data found

*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.